CV
NASD CapsoVision, Inc.$6.17 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.17, $0.23 below the day’s high of $6.40
- YTD change
- -42.28%
- vs 20-day SMA
- -3.19%
- vs 200-day SMA
- -8.19%
Price ranges
Price & Performance
-0.53 (-7.91%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 59.9% away from all-time highs of $15.37
- CV is down 42% since the beginning of the year
- CV is up 29% over the past 12 months
- CV is up 4% over the past 1 month
- 6% of all CV investors are betting against CV
CV reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +34.9%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +0.00%
- vs 8-day SMA
- -4.27%
No alerts for CV in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
